Compare TTK HEALTHCARE with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE DR. REDDYS LAB TTK HEALTHCARE/
DR. REDDYS LAB
 
P/E (TTM) x 17.3 21.5 80.5% View Chart
P/BV x 1.4 3.2 43.1% View Chart
Dividend Yield % 1.1 0.7 151.9%  

Financials

 TTK HEALTHCARE   DR. REDDYS LAB
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
DR. REDDYS LAB
Mar-19
TTK HEALTHCARE/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,2152,875 42.3%   
Low Rs6101,888 32.3%   
Sales per share (Unadj.) Rs444.4930.2 47.8%  
Earnings per share (Unadj.) Rs17.2117.4 14.7%  
Cash flow per share (Unadj.) Rs27.6185.8 14.9%  
Dividends per share (Unadj.) Rs5.0020.00 25.0%  
Dividend yield (eoy) %0.50.8 65.2%  
Book value per share (Unadj.) Rs177.9844.4 21.1%  
Shares outstanding (eoy) m14.13166.07 8.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.12.6 80.2%   
Avg P/E ratio x52.920.3 260.9%  
P/CF ratio (eoy) x33.012.8 257.6%  
Price / Book Value ratio x5.12.8 181.8%  
Dividend payout %29.017.0 170.2%   
Avg Mkt Cap Rs m12,894395,496 3.3%   
No. of employees `0002.322.0 10.5%   
Total wages/salary Rs m1,30733,562 3.9%   
Avg. sales/employee Rs Th2,715.77,032.8 38.6%   
Avg. wages/employee Rs Th565.31,527.9 37.0%   
Avg. net profit/employee Rs Th105.4887.7 11.9%   
INCOME DATA
Net Sales Rs m6,279154,482 4.1%  
Other income Rs m783,375 2.3%   
Total revenues Rs m6,356157,857 4.0%   
Gross profit Rs m49631,782 1.6%  
Depreciation Rs m14711,348 1.3%   
Interest Rs m34889 3.8%   
Profit before tax Rs m39322,920 1.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1493,858 3.9%   
Profit after tax Rs m24419,500 1.2%  
Gross profit margin %7.920.6 38.4%  
Effective tax rate %37.916.8 225.3%   
Net profit margin %3.912.6 30.7%  
BALANCE SHEET DATA
Current assets Rs m2,717111,101 2.4%   
Current liabilities Rs m1,57158,973 2.7%   
Net working cap to sales %18.333.7 54.1%  
Current ratio x1.71.9 91.8%  
Inventory Days Days3279 40.5%  
Debtors Days Days4794 49.5%  
Net fixed assets Rs m991101,245 1.0%   
Share capital Rs m141830 17.0%   
"Free" reserves Rs m2,373139,406 1.7%   
Net worth Rs m2,514140,236 1.8%   
Long term debt Rs m322,000 0.0%   
Total assets Rs m4,158224,656 1.9%  
Interest coverage x12.626.8 47.1%   
Debt to equity ratio x00.2 0.9%  
Sales to assets ratio x1.50.7 219.6%   
Return on assets %6.79.1 73.5%  
Return on equity %9.713.9 69.7%  
Return on capital %16.914.9 113.3%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22588,673 0.3%   
Fx outflow Rs m7119,104 0.4%   
Net fx Rs m15469,569 0.2%   
CASH FLOW
From Operations Rs m17328,704 0.6%  
From Investments Rs m97-7,727 -1.2%  
From Financial Activity Rs m-307-21,326 1.4%  
Net Cashflow Rs m-38-314 12.0%  

Share Holding

Indian Promoters % 65.4 25.5 256.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 5.4 68.5%  
FIIs % 5.2 35.3 14.7%  
ADR/GDR % 0.0 18.5 -  
Free float % 25.8 15.3 168.6%  
Shareholders   12,723 75,885 16.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   SUVEN LIFESCIENCES  SHASUN PHARMA  SANOFI INDIA  FDC LTD.  NATCO PHARMA  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Oct 18, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS